logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Astrazeneca Pharma India Ltd
    Industry :  Pharmaceuticals - Multinational
    BSE Code
    ISIN Demat
    Book Value()
    506820
    INE203A01020
    271.74
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    ASTRAZEN
    138.16
    17784.38
    EPS(TTM)
    Face Value()
    Div & Yield %:
    51.49
    2
    0.34
     
Mahindra & Mahindra Ltd
British International Investment to further invest Rs 650 cr in Mahindra Electric Automobile
Dec 30,2024
Mahindra & Mahindra announced that in relation to British International Investment Plc.'s (BII) investment in Mahindra Electric Automobile (MEAL), the company and BII have jointly assessed the funding requirement for MEAL. Basis the assessment, the Company and BII have today mutually agreed that the final tranche of BII Group's (i.e. BII and/or BII India EV LLP) investment would be Rs. 650 crore to be completed by 31 March 2025, as against earlier planned investment of Rs. 725 crore.

Consequently, the total investment by BII Group in MEAL would be Rs. 1,850 crore resulting in BII Group having a shareholding in the range of 2.64% to 4.58% of the Share Capital of MEAL, on a fully diluted basis.

Above change will have no bearing on MEAL's overall business plan.